MIND Technology Announces Fiscal 2026 Third Quarter Earnings Release and Conference Call Schedule

MIND Technology, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2026 third quarter ended October 31, 2025 after the market closes on Tuesday, December 9, 2025. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Wednesday, December […]

Jack Henry Leaders to Present at Upcoming Conferences for UBS, Nasdaq

Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today thatit will be participating in the upcoming conferences: https://mma.prnewswire.com/media/1868509/Jack_Henry_and_Associates_Logo.jpg — Greg Adelson, President & CEO, will present at the UBS Global Technology and AI Conference 2025 on December 3. The presentation takes place at 6:15 p.m. ET. A live webcast of the presentation will be accessible

HP Inc. Reports Fiscal 2025 Full Year and Fourth Quarter Results

HP Inc. Reports Fiscal 2025 Full Year and Fourth Quarter Results GlobeNewswire November 25, 2025 PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — HP (NYSE: HPQ) Fiscal 2025 GAAP diluted net earnings per share (“EPS”) of $2.65, down 5.7% from the prior year period Fiscal 2025 non-GAAP diluted net EPS of $3.12, down 9.0%

Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference

Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 25, 2025 DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will present at the Piper Sandler Healthcare Conference on

Onity Group to Present at Upcoming Investor Conference

Onity Group to Present at Upcoming Investor Conference GlobeNewswire November 25, 2025 WEST PALM BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that Sean O'Neil, Executive Vice President and Chief Financial Officer with Onity Group, will present and host meetings with investors at the

Applied Optoelectronics to Present at the Raymond James 2025 TMT & Consumer Conference

Applied Optoelectronics to Present at the Raymond James 2025 TMT & Consumer Conference GlobeNewswire November 25, 2025 SUGAR LAND, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced the Company will present via a fireside

Anaptys Announces Participation in December Investor Conferences

Anaptys Announces Participation in December Investor Conferences GlobeNewswire November 25, 2025 SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled

Kaixin Holdings Announces Share Consolidation

Kaixin Holdings Announces Share Consolidation GlobeNewswire November 25, 2025 BEIJING, Nov. 25, 2025 (GLOBE NEWSWIRE) — Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) announced that it will effect a share consolidation of its ordinary shares, par value $0.045 each, at a ratio of 1-for-30, with a post-share consolidation par value $1.35 each, effective on

James Hardie Industries plc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – JHX

James Hardie Industries plc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – JHX GlobeNewswire November 25, 2025 NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. (“James Hardie Industries plc.” or the “Company”) (NYSE: JHX) of a

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health Actionable offering helps enable earlier, more personalized breast cancer interventions GlobeNewswire November 25, 2025 BOSTON and SALT LAKE CITY and FULTON, Md., Nov. 25, 2025 (GLOBE NEWSWIRE) — Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView, today

Scroll to Top